Compare Aventis Pharma with Abbott India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs ABBOTT INDIA - Comparison Results

SANOFI INDIA     Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

ABBOTT INDIA 
   Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANOFI INDIA ABBOTT INDIA SANOFI INDIA/
ABBOTT INDIA
 
P/E (TTM) x 35.1 44.7 78.4% View Chart
P/BV x 6.1 12.8 47.9% View Chart
Dividend Yield % 1.4 0.5 263.3%  

Financials

 SANOFI INDIA   ABBOTT INDIA
EQUITY SHARE DATA
    SANOFI INDIA
Dec-18
ABBOTT INDIA
Mar-18
SANOFI INDIA/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs6,8406,110 111.9%   
Low Rs4,6303,996 115.9%   
Sales per share (Unadj.) Rs1,203.11,552.2 77.5%  
Earnings per share (Unadj.) Rs165.3188.8 87.5%  
Cash flow per share (Unadj.) Rs209.9196.4 106.8%  
Dividends per share (Unadj.) Rs84.0055.00 152.7%  
Dividend yield (eoy) %1.51.1 134.6%  
Book value per share (Unadj.) Rs963.6796.6 121.0%  
Shares outstanding (eoy) m23.0321.25 108.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.83.3 146.4%   
Avg P/E ratio x34.726.8 129.7%  
P/CF ratio (eoy) x27.325.7 106.2%  
Price / Book Value ratio x6.06.3 93.8%  
Dividend payout %50.829.1 174.5%   
Avg Mkt Cap Rs m132,078107,376 123.0%   
No. of employees `0003.33.3 99.4%   
Total wages/salary Rs m4,0683,937 103.3%   
Avg. sales/employee Rs Th8,393.89,929.3 84.5%   
Avg. wages/employee Rs Th1,232.41,185.1 104.0%   
Avg. net profit/employee Rs Th1,153.01,207.7 95.5%   
INCOME DATA
Net Sales Rs m27,70832,985 84.0%  
Other income Rs m8971,170 76.7%   
Total revenues Rs m28,60534,155 83.8%   
Gross profit Rs m6,2355,245 118.9%  
Depreciation Rs m1,027162 634.3%   
Interest Rs m738 18.3%   
Profit before tax Rs m6,0986,215 98.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,2922,203 104.1%   
Profit after tax Rs m3,8064,012 94.9%  
Gross profit margin %22.515.9 141.5%  
Effective tax rate %37.635.4 106.0%   
Net profit margin %13.712.2 112.9%  
BALANCE SHEET DATA
Current assets Rs m15,92222,655 70.3%   
Current liabilities Rs m6,2356,681 93.3%   
Net working cap to sales %35.048.4 72.2%  
Current ratio x2.63.4 75.3%  
Inventory Days Days6465 98.3%  
Debtors Days Days2129 71.6%  
Net fixed assets Rs m7,539835 902.4%   
Share capital Rs m230213 108.2%   
"Free" reserves Rs m21,96216,715 131.4%   
Net worth Rs m22,19216,928 131.1%   
Long term debt Rs m00-   
Total assets Rs m29,83924,162 123.5%  
Interest coverage x872.1163.7 532.8%   
Debt to equity ratio x00-  
Sales to assets ratio x0.91.4 68.0%   
Return on assets %12.816.8 76.2%  
Return on equity %17.223.7 72.4%  
Return on capital %27.536.9 74.5%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m7,587369 2,058.7%   
Fx outflow Rs m7,1453,807 187.7%   
Net fx Rs m442-3,438 -12.9%   
CASH FLOW
From Operations Rs m3,7391,527 244.9%  
From Investments Rs m-731-2,148 34.0%  
From Financial Activity Rs m-1,972-1,024 192.5%  
Net Cashflow Rs m1,036-1,646 -63.0%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 60.4 75.0 80.5%  
Indian inst/Mut Fund % 14.4 7.9 182.3%  
FIIs % 14.6 0.1 14,600.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.5 17.1 61.4%  
Shareholders   15,184 18,270 83.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANOFI INDIA With:   SHASUN PHARMA  WYETH LTD  ASTRAZENECA PHARMA  SUVEN LIFESCIENCES  CIPLA  

Compare SANOFI INDIA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex's Journey From 640 Points Down to 2,000 Points Up(Podcast)

What a week it was! While crude oil prices dragged the Indian stock markets lower, finance minister Nirmala Sitharaman's boosters sent markets soaring and how!

Related Views on News

ABBOTT INDIA Announces Quarterly Results (1QFY20); Net Profit Up 41.9% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 41.9% YoY). Sales on the other hand came in at Rs 10 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (1QFY20); Net Profit Down 2.2% (Quarterly Result Update)

Jul 31, 2019 | Updated on Jul 31, 2019

For the quarter ended June 2019, SANOFI INDIA has posted a net profit of Rs 974 m (down 2.2% YoY). Sales on the other hand came in at Rs 7 bn (up 9.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (4QFY19); Net Profit Up 13.1% (Quarterly Result Update)

May 28, 2019 | Updated on May 28, 2019

For the quarter ended March 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 13.1% YoY). Sales on the other hand came in at Rs 9 bn (up 15.0% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (4QFY19); Net Profit Up 12.6% (Quarterly Result Update)

May 8, 2019 | Updated on May 8, 2019

For the quarter ended March 2019, SANOFI INDIA has posted a net profit of Rs 929 m (up 12.6% YoY). Sales on the other hand came in at Rs 7 bn (up 16.1% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA 2017-18 Annual Report Analysis (Annual Result Update)

Apr 16, 2019 | Updated on Apr 16, 2019

Here's an analysis of the annual report of SANOFI INDIA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SANOFI INDIA. Also includes updates on the valuation of SANOFI INDIA.

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Rare Opportunity to Buy the Top 5 Stocks in the Market(The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

This Company Will Do Well Despite the Slowdown(The 5 Minute Wrapup)

Sep 11, 2019

How financial inclusion provides a big runway for this stock recommendation.

The 5 Best Trading Opportunities I've Spotted(Profit Hunter)

Sep 13, 2019

These 10 auto stocks should be in your watchlist for the next 32 months. Paste them on your workstation NOW.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SANOFI INDIA SHARE PRICE


Sep 20, 2019 (Close)

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SANOFI INDIA 8-QTR ANALYSIS

COMPARE SANOFI INDIA WITH

MARKET STATS